Roche's PD-L1 franchise player nabs priority review; One of world's first psychedelics research institutes opens in Australia
The FDA has just put Genentech’s latest shot at adding blockbuster sales for Tecentriq on the regulator’s inside track.
Roche said Tuesday that the agency …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
